Read what we’re doing to ensure PCCA Formulas for compounding sterile preparations comply with USP Chapter 797 revisions.

Matt Martin, PharmD, BCSCP, PCCA Director of Clinical Services, reviews USP 797revisions and impacts on compounding pharmacies in the fourth of a four-part series.

A modular compounding cleanroom is a great way to meet evolving regulatory requirements and standards. Learn the basics of a modular cleanroom in the first in a series of articles on Modular Compounding Cleanrooms.

Thank you to all of our readers and subscribers for supporting the PCCA blog, your support is what makes it the best compounding pharmacy blog online! We’re grateful to be able to produce content that professionals in the pharmacy compounding industry find valuable. With that said, come check out the top five, most valuable PCCA Blog Posts of 2019 that you might have missed!

PCCA's Director of Formulation Development Melissa Merrell Rhoads, PharmD, provides part two in a set of posts detailing the upcoming changes to our formulas based upon the new USP guidelines. This particular section focuses on USP <797>.

PCCA's Director of Formulation Development Melissa Merrell Rhoads, PharmD, provides part one in a set of posts detailing the upcoming changes to our formulas based upon the new USP guidelines.

Want some clarity on USP <797> and USP <800> updates? Our August updates to PCCA Play are designed to do just that with a free presentation from PCCA Education and Training Manager Jerra Banwarth, RPh, FIACP and Eagle President Ross Caputo, PhD. In another video, subscribers to PCCA Play can watch Eagle Vice President of Operations Megan Jeffrey Liotta, MS, discuss USP <797> regulation updates.

Jeff Gloyer is an engineer I with Eagle. He has experience working with multidisciplinary teams to implement the engineering design process. Here he discusses considerations that compounding pharmacies need to take in order to ensure they are USP <797> and <800> compliant.